Showing results (51-60 of 56) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|July 31, 2023
Retinal Thickness in Essential Tremor and Early Parkinson Disease: Exploring Diagnostic InsightsClaudio Terravecchia, Giovanni Mostile, Clara G Chisari, et al.Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 16, 2025
Real-world effectiveness and safety of ofatumumab in relapsing-remitting multiple sclerosis: Insights from naïve and switch patientsClara G Chisari, Salvatore Lo Fermo, Salvatore Iacono, et al.Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 23, 2023
Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY)Clara G Chisari, Assunta Bianco, Vincenzo Brescia Morra, et al.Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|May 7, 2024
Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched studyClara G Chisari, Umberto Aguglia, Maria Pia Amato, et al.Journal of Neurology|June 28, 2021
PML risk is the main factor driving the choice of discontinuing natalizumab in a large multiple sclerosis population: results from an Italian multicenter retrospective studyClara G Chisari, Giancarlo Comi, Massimo Filippi, et al.Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 18, 2025
First-year treatment response predicts the following 5-year disease course in patients with relapsing-remitting multiple sclerosisSimona Toscano, Tim Spelman, Serkan Ozakbas, et al.Pageof 6